Dr. Espay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 Piedmont Avenue
Ste. 3100
Cincinnati, OH 45219Phone+1 513-475-8730Fax+1 513-475-8033
Summary
- Dr. Alberto Espay is Professor and Endowed Chair of the James J. and Joan A. Gardner Center for Parkinson’s disease at the University of Cincinnati. He has published over 300 peer-reviewed research articles and 8 books, including Common Movement Disorders Pitfalls, which received the Highly Commended BMA Medical Book Award in 2013 and Brain Fables, the Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer them, coauthored with Parkinson patient and advocate Benjamin Stecher, selected by the Association of American Publishers for the PROSE Award honoring the best scholarly work in Neuroscience published in 2020. He has served as Chair of the Movement Disorders Section of the American Academy of Neurology, Associate Editor of the Movement Disorders journal, and on the Executive Committee of the Parkinson Study Group. Among other honors, he has received the Cincinnati Business Courier’s Health Care Hero award, the Spanish Society of Neurology’s Cotzias award, and honorary membership in the Mexican Academy of Neurology. He currently serves as President-Elect of the Pan-American Section of the International Parkinson and Movement Disorders Society. With colleagues at the University of Cincinnati, he recently launched the first biomarker study of aging (CCBPstudy.com), designed to match people with neurodegenerative disorders to available therapies from which they are most biologically suitable to benefit, regardless of their clinical diagnoses.
Education & Training
- University of TorontoM.Sc., Clinical Epidemiology and Health Care Research, 2003 - 2005
- Indiana University School of MedicineResidency, Neurology, 1998 - 2001
- Ascension St Vincent Hospital IndianapolisInternship, Transitional Year, 1997 - 1998
- Central University of VenezuelaClass of 1994
- Liceo de AplicacionB.S., 1987
Certifications & Licensure
- OH State Medical License 2005 - 2027
- NY State Medical License 2002 - 2005
- NM State Medical License 1996 - 1996
- American Board of Psychiatry and Neurology Neurology
- National Board of Physicians and Surgeons Neurology
Awards, Honors, & Recognition
- Top Doctor Cincinnati Magazine, 2014
- Fellow American Academy of Neurology (FAAN), 2013
- Fellow American Neurological Association (FANA), 2013
- Join now to see all
Clinical Trials
- Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease Start of enrollment: 2007 May 01
- Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease Start of enrollment: 2007 Dec 01
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 135 citationsCortical and spinal abnormalities in psychogenic dystonia.Alberto J. Espay, Francesca Morgante, Jamie Purzner, Carolyn Gunraj, Anthony E. Lang
Annals of Neurology. 2006-05-01 - 1 citationsAbnormal Cerebrospinal Fluid Cytology in Functional Movement Disorders.Tereza Serranová, Matěj Slovák, Zuzana Forejtová, Tomáš Sieger, Petr Dušek
Psychosomatic Medicine. 2024-03-25 - 87 citationsPhenotype-Specific Diagnosis of Functional (Psychogenic) Movement DisordersAlberto J. Espay, Anthony E. Lang
Current Neurology and Neuroscience Reports. 2015-04-23
Journal Articles
- Levodopa‐Induced Dyskinesia in Parkinson Disease: Current and Evolving ConceptsAristide Merola, Alberto J Espay, Annals of Neurology
- Impaired Emotion Processing in Functional (Psychogenic) Tremor: A Functional Magnetic Resonance Imaging StudyThomas Maloney, Alberto J Espay, Jerzy P Szaflarski, ScienceDirect
- Double-Blind, Double-Dummy, Study of Continuous Intrajejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s DiseaseOlanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Ohtman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Anton..., Lancet Neurol, 12/19/2013
- Join now to see all
Press Mentions
- Alzheimer's Data WithdrawnNovember 11th, 2024
- Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 DiabetesOctober 24th, 2024
- Ozempic Linked to Lower Alzheimer's Risk in People with Type 2 DiabetesOctober 24th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: